Nieminen M M, Lahdensuo A, Kellomaeki L, Karvonen J, Muittari A
Department of Pulmonary Diseases, Tampere University Central Hospital, Pikonlinna, Finland.
Thorax. 1988 Nov;43(11):896-900. doi: 10.1136/thx.43.11.896.
A new inhalation synchronised dosimeter triggered by low inspiratory flow rates has been assessed. The methacholine challenge test using dosimeter nebulisation with controlled tidal breathing was compared with continuous nebulisation using De Vilbiss No 40 nebulisers with deep inhalations in 11 asthmatic subjects. Within subject PD20 FEV1 values were lower with the dosimeter method than with the continuous nebulisation method (geometric means 158 and 588 micrograms). The repeatability of the dosimeter method with controlled tidal breathing was studied in 11 asthmatic subjects, and the 95% range for a single measurement was +/- 0.72 doubling doses of methacholine. The dosimeter method has greater efficacy because aerosol is delivered during the first part of an inhalation, minimising loss of aerosol outside the respiratory tract. The dosimeter technique combined with controlled tidal breathing appears to be a useful method for carrying out standardised non-specific bronchoprovocation tests.
一种由低吸气流量触发的新型吸入同步剂量计已得到评估。在11名哮喘患者中,将使用剂量计雾化并控制潮气量呼吸的乙酰甲胆碱激发试验与使用德维比斯40号雾化器进行深吸气的持续雾化进行了比较。在受试者中,剂量计法的PD20 FEV1值低于持续雾化法(几何平均值分别为158和588微克)。在11名哮喘患者中研究了剂量计法在控制潮气量呼吸时的重复性,单次测量的95%范围为乙酰甲胆碱加倍剂量的±0.72。剂量计法具有更高的效率,因为气溶胶在吸气的第一部分输送,将呼吸道外的气溶胶损失降至最低。剂量计技术与控制潮气量呼吸相结合似乎是进行标准化非特异性支气管激发试验的一种有用方法。